Work Here?
About Medable
Industries
Enterprise Software
Healthcare
Company Size
201-500
Company Stage
Series D
Total Funding
$492.4M
Headquarters
Palo Alto, California
Founded
2016
Overview
Medable offers a digital platform that streamlines the clinical trial process for healthcare organizations, including pharmaceutical companies. Its tools facilitate participant onboarding, data collection, study notifications, and real-time reporting, ensuring high-quality data for validating drug effectiveness. Medable stands out with its user-friendly design, scalability, and extensive decentralized clinical trial network, operating in over 60 countries and 120 languages. The company's goal is to leverage the growing decentralized clinical trial market, projected to exceed $12 billion by 2030.
Simplify's Take
What believers are saying
- Integration with Google Cloud enhances scalability and global accessibility.
- Generative AI reduces trial startup time, improving efficiency and patient outcomes.
- CNIL approval expands opportunities for digital trials across the European Union.
What critics are saying
- AI-driven SaaS competition could threaten Medable's market share.
- Dependency on Google Cloud poses operational risks if disruptions occur.
- Rapid AI adoption may lead to data privacy and security concerns.
What makes Medable unique
- Medable offers a unified platform for decentralized clinical trials globally.
- The platform supports 60+ countries and 120 languages, enhancing global reach.
- Medable's no-code platform empowers non-technical users to design complex trials.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$492.4M
Above
Industry Average
Funded Over
5 Rounds
Tiger GlobalIndustry standards
Benefits
Health & wellness
401k
Remote first
Career development
Military support
Time away
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↓ -1%2 year growth
↑ 0%Medable partnered closely with Servier - one of the largest pharmaceutical sponsors in France - over six months to obtain CNIL approval.
Silicon Valley investors are seeing a wave of opportunities in specialized software for laundromats, chiropractors and other previously overlooked industries as artificial intelligence improves profit potential. The shift comes as AI technology allows software companies to expand from basic business management tools into handling sales, marketing and customer service tasks that were once too complex to automate, potentially increasing revenue per customer tenfold while slashing acquisition costs, according to new research from venture capital firm Andreessen Horowitz. “In vertical SaaS, AI is making previously unprofitable markets viable by increasing customer value and driving down costs,” VisionX founder and CEO Antwyne DeLonde told PYMNTS. “With AI automating complex tasks and delivering personalized solutions, software companies can now serve smaller, niche markets that were once financially out of reach.”
Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows.
Medable's platform will be seamlessly integrated with Google Cloud Marketplace, which will enable users to access Medable's recently launched Studio, a software as a service (SaaS) solution designed to provide pharmaceutical companies control and transparency in clinical trial design, execution, and data management.
What You Should Know:– Medable Inc., a leader in clinical development technology, has announced Medable AI, a suite of generative AI capabilities designed to revolutionize the clinical trial startup process. Medable AI empowers sponsors and clinical research organizations (CROs) to build digital and decentralized trials faster, with greater efficiency and control.– The launch of Medable AI is part of a broader AI strategy for Medable, with plans to expand AI capabilities across its platform in the future. This reflects the company’s commitment to leveraging cutting-edge technology to accelerate clinical development and improve patient outcomes.Accelerating Time to First Patient In (FPI)Medable AI, integrated into the Medable Studio platform, automates time-consuming manual tasks that traditionally slow down clinical trial startup. By streamlining processes and eliminating repetitive work, Medable AI significantly reduces the time to First Patient In (FPI).For example, building multiple outcomes assessments for a study, a process that typically takes days, can now be completed in just 30 minutes with Medable AI, according to early metrics. This accelerated timeline represents a major breakthrough for the industry, moving towards the ambitious goal of one-day study startup.Enhanced Efficiency and ControlMedable AI offers a range of capabilities to enhance the trial build process:Automated eCOA Creation: Automatically converts existing outcomes assessments into fully digital eCOAs in seconds.Automatically converts existing outcomes assessments into fully digital eCOAs in seconds. Simplified Editing: Provides a user-friendly, ChatGPT-like interface for easy editing of assessments.Provides a user-friendly, ChatGPT-like interface for easy editing of assessments
Medable is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Medable
Industries
Enterprise Software
Healthcare
Company Size
201-500
Company Stage
Series D
Total Funding
$492.4M
Headquarters
Palo Alto, California
Founded
2016
Medable is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today